{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:27:21Z","timestamp":1790771241146,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.nano.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T02:01:22Z","timestamp":1423015282000},"page":"1189-1199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"title":["Inhalable nanoparticulate powders for respiratory delivery"],"prefix":"10.1016","volume":"11","author":[{"given":"Priya","family":"Muralidharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Malapit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Mallory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Don","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.nano.2015.01.007_bb0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/iub.481","article-title":"Lung vascular targeting through inhalation delivery: insight from filamentous viruses and other shapes","volume":"63","author":"Mahmud","year":"2011","journal-title":"IUBMB Life"},{"issue":"12","key":"10.1016\/j.nano.2015.01.007_bb0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tibtech.2007.09.005","article-title":"Nanoparticles for drug delivery to the lungs","volume":"25","author":"Sung","year":"2007","journal-title":"Trends Biotechnol"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(03)00359-6","article-title":"Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery","volume":"93","author":"Bhavane","year":"2003","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0020","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pharmthera.2013.06.008","article-title":"New perspectives in nanomedicine","volume":"140","author":"Thorley","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.nano.2015.01.007_bb0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jac\/dki027","article-title":"Antitubercular inhaled therapy: opportunities, progress and challenges","volume":"55","author":"Pandey","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.nano.2015.01.007_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2014.05.058","article-title":"Controlled delivery of inhaled therapeutic agents","volume":"190","author":"Hickey","year":"2014","journal-title":"J Control Release."},{"key":"10.1016\/j.nano.2015.01.007_bb0035","first-page":"1269","article-title":"Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery","volume":"8","author":"Wu","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.01.007_bb0040","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/IJN.S4937","article-title":"Nanomedicine in pulmonary delivery","volume":"4","author":"Mansour","year":"2009","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2015.01.007_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12280","article-title":"Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications","author":"Kannan","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.nano.2015.01.007_bb0050","first-page":"59","article-title":"Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation","volume":"7","author":"Wu","year":"2013","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"10.1016\/j.nano.2015.01.007_bb0055","first-page":"652","article-title":"Drug properties affecting aerosol behavior","volume":"45","author":"Suarez","year":"2000","journal-title":"Respir Care"},{"key":"10.1016\/j.nano.2015.01.007_bb0060","first-page":"2617","article-title":"<601> aerosols, nasal sprays, metered-dose inhalers, and dry powder inhalers monograph","volume":"vol. 29\/24","year":"2006"},{"issue":"12","key":"10.1016\/j.nano.2015.01.007_bb0065","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","article-title":"Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size","volume":"172","author":"Usmani","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.nano.2015.01.007_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/15298668091424933","article-title":"Experimental determination of the regional deposition of aerosol particles in the human respiratory tract","volume":"41","author":"Stahlhofen","year":"1980","journal-title":"Am Ind Hyg Assoc J"},{"key":"10.1016\/j.nano.2015.01.007_bb0075","series-title":"Textbook of respiratory medicine","author":"Murray","year":"1988"},{"issue":"1\u20134","key":"10.1016\/j.nano.2015.01.007_bb0080","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/annhyg\/26.1.33","article-title":"Comparison of the criteria for sampling 'inhalable' and 'respirable' aerosols","volume":"26","author":"Raabe","year":"1982","journal-title":"Ann Occup Hyg"},{"issue":"9","key":"10.1016\/j.nano.2015.01.007_bb0085","first-page":"1209","article-title":"Dry powder inhaler formulation","volume":"50","author":"Telko","year":"2005","journal-title":"Respiratory care"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0090","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2006.10.009","article-title":"Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids","volume":"333","author":"Hadinoto","year":"2007","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"10.1016\/j.nano.2015.01.007_bb0100","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1166\/jbn.2010.1116","article-title":"Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells","volume":"6","author":"Cheow","year":"2010","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.nano.2015.01.007_bb0105","first-page":"275","volume":"8","author":"Meenach","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"32","key":"10.1016\/j.nano.2015.01.007_bb0110","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.nano.2015.01.007_bb0115","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1023\/A:1019881706159","article-title":"Insoluble powder formulation as an effective nasal drug delivery system","volume":"19","author":"Ishikawa","year":"2002","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jps.20718","article-title":"Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?","volume":"96","author":"Illum","year":"2007","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"PLA-PEG particles as nasal protein carriers: the influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int J Pharm"},{"issue":"3\u20134","key":"10.1016\/j.nano.2015.01.007_bb0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejps.2013.07.006","article-title":"The effect of polymer coatings on physicochemical properties of spray-dried liposomes for nasal delivery of BSA","volume":"50","author":"Chen","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"8","key":"10.1016\/j.nano.2015.01.007_bb0135","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s12272-013-0043-4","article-title":"Dry-powder form of chitosan nanospheres containing influenza virus and adjuvants for nasal immunization","volume":"36","author":"Dehghan","year":"2013","journal-title":"Arch Pharm Res"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/jps.22742","article-title":"Stable dry powder formulation for nasal delivery of anthrax vaccine","volume":"101","author":"Wang","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2015.01.007_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1871523011109030215","article-title":"Pulmonary and nasal anti-inflammatory and anti-allergy inhalation aerosol delivery systems","author":"Wu","year":"2011","journal-title":"Anti-Inflammatory Anti-Allergy Agents Med Chem"},{"key":"10.1016\/j.nano.2015.01.007_bb0150","series-title":"Modern Pharmaceutics","first-page":"191","article-title":"Delivery of drugs by the pulmonary route","author":"Hickey","year":"2009"},{"key":"10.1016\/j.nano.2015.01.007_bb0155","series-title":"Modified-release drug delivery technology vol 2","first-page":"573","article-title":"Formulation challenges of powders for the delivery of small molecular weight molecules as aerosols","author":"Hickey","year":"2008"},{"issue":"5","key":"10.1016\/j.nano.2015.01.007_bb0160","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jps.20916","article-title":"Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics","volume":"96","author":"Hickey","year":"2007","journal-title":"J Pharm Sci"},{"issue":"5","key":"10.1016\/j.nano.2015.01.007_bb0165","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/jps.20943","article-title":"Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics","volume":"96","author":"Hickey","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2015.01.007_bb0170","series-title":"Controlled pulmonary drug delivery","author":"Hugh","year":"2011"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jamp.2013.1078","article-title":"Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate\/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers","volume":"27","author":"Li","year":"2014","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"5","key":"10.1016\/j.nano.2015.01.007_bb0180","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.drudis.2013.11.013","article-title":"Alternative carriers in dry powder inhaler formulations","volume":"19","author":"Rahimpour","year":"2014","journal-title":"Drug Discov Today"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/med.20140","article-title":"Nanoparticle formulations in pulmonary drug delivery","volume":"29","author":"Bailey","year":"2009","journal-title":"Med Res Rev"},{"issue":"10","key":"10.1016\/j.nano.2015.01.007_bb0190","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4155\/tde.11.100","article-title":"Pulmonary delivery of inhalable nanoparticles: dry powder inhalers","volume":"2","author":"Al-Hallak","year":"2011","journal-title":"Ther Deliv"},{"issue":"6","key":"10.1016\/j.nano.2015.01.007_bb0195","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","article-title":"Polymeric nanoparticles for pulmonary protein and DNA delivery","volume":"10","author":"Menon","year":"2014","journal-title":"Acta biomaterialia"},{"issue":"9","key":"10.1016\/j.nano.2015.01.007_bb0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt0914-851a","article-title":"Sanofi to propel inhalable insulin Afrezza into market","volume":"32","author":"Kling","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nano.2015.01.007_bb0205","article-title":"Particle interactions in dry powder inhaler unit processes: a review","volume":"451\u2013482","author":"Xu","year":"2012","journal-title":"J Adhes Sci Technol"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2010.10.035","article-title":"Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model","volume":"150","author":"Roa","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2015.01.007_bb0215","series-title":"Nanomedicine in drug delivery","author":"Kumar","year":"2013"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0220","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11095-006-9174-3","article-title":"Particle engineering for pulmonary drug delivery","volume":"24","author":"Chow","year":"2007","journal-title":"Pharm Res"},{"issue":"36","key":"10.1016\/j.nano.2015.01.007_bb0225","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0230","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jbm.a.30711","article-title":"Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake","volume":"78","author":"Vonarbourg","year":"2006","journal-title":"J Biomed Mater Res A"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jbm.a.20117","article-title":"Casual cell surface remodeling using biocompatible lipid-poly(ethylene glycol)(n): development of stealth cells and monitoring of cell membrane behavior in serum-supplemented conditions","volume":"70A","author":"Chung","year":"2004","journal-title":"J Biomed Mater Res A"},{"issue":"4","key":"10.1016\/j.nano.2015.01.007_bb0245","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics5040542","article-title":"Surface engineering of liposomes for stealth behavior","volume":"5","author":"Nag","year":"2013","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2007.10.008","article-title":"Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection","volume":"125","author":"Youn","year":"2008","journal-title":"J Control Release"},{"issue":"5320","key":"10.1016\/j.nano.2015.01.007_bb0255","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1126\/science.276.5320.1868","article-title":"Large porous particles for pulmonary drug delivery","volume":"276","author":"Edwards","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0260","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/pharmaceutics6020333","article-title":"Inhalable PEGylated phospholipid nanocarriers and PEGylated therapeutics for respiratory delivery as aerosolized colloidal dispersions and dry powder inhalers","volume":"6","author":"Muralidharan","year":"2014","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1208\/s12249-007-9024-6","article-title":"Development of spray dried liposomal dry powder inhaler of Dapsone","volume":"9","author":"Chougule","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"11","key":"10.1016\/j.nano.2015.01.007_bb0270","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1002\/jps.21673","article-title":"Simultaneously manufactured nano-in-micro (SIMANIM) particles for dry-powder modified-release delivery of antibodies","volume":"98","author":"Kaye","year":"2009","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijpharm.2013.02.004","article-title":"Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel","volume":"446","author":"Wang","year":"2013","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jconrel.2011.08.011","article-title":"Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA","volume":"157","author":"Jensen","year":"2012","journal-title":"J Control Release"},{"issue":"5","key":"10.1016\/j.nano.2015.01.007_bb0285","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejps.2012.02.024","article-title":"Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation","volume":"46","author":"Yang","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"11","key":"10.1016\/j.nano.2015.01.007_bb0290","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/adma.201204750","article-title":"Engineering the assemblies of biomaterial nanocarriers for delivery of multiple theranostic agents with enhanced antitumor efficacy","volume":"25","author":"Wang","year":"2013","journal-title":"Adv Mater"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0295","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2012.05.036","article-title":"Dry powder inhaler formulation of lipid-polymer hybrid nanoparticles via electrostatically-driven nanoparticle assembly onto microscale carrier particles","volume":"434","author":"Yang","year":"2012","journal-title":"Int J Pharm"},{"issue":"6","key":"10.1016\/j.nano.2015.01.007_bb0300","doi-asserted-by":"crossref","first-page":"725","DOI":"10.4155\/tde.12.42","article-title":"Distribution of effervescent inhalable nanoparticles after pulmonary delivery: an in vivo study","volume":"3","author":"Al-Hallak","year":"2012","journal-title":"Ther Deliv"},{"issue":"9","key":"10.1016\/j.nano.2015.01.007_bb0305","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/03639040802149079","article-title":"Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles","volume":"34","author":"Azarmi","year":"2008","journal-title":"Drug Dev Ind Pharm"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0310","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejpb.2006.10.021","article-title":"Effervescent dry powder for respiratory drug delivery","volume":"65","author":"Ely","year":"2007","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2015.01.007_bb0315","author":"Michael","year":"2008"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0320","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/jamp.2013.1078","article-title":"Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate\/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers","volume":"27","author":"Li","year":"2014","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0325","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.colsurfb.2009.02.001","article-title":"Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer","volume":"71","author":"Tomoda","year":"2009","journal-title":"Colloids Surf B: Biointerfaces"},{"key":"10.1016\/j.nano.2015.01.007_bb0330","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejps.2013.10.016","article-title":"Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate\/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery","volume":"52","author":"Li","year":"2014","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0335","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijpharm.2013.06.047","article-title":"Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols","volume":"455","author":"Park","year":"2013","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.nano.2015.01.007_bb0340","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ejps.2013.05.012","article-title":"Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer","volume":"49","author":"Meenach","year":"2013","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0345","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.colsurfb.2007.07.016","article-title":"Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles","volume":"61","author":"Tomoda","year":"2008","journal-title":"Colloids Surf B: Biointerfaces"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0350","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijpharm.2010.11.021","article-title":"Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants","volume":"404","author":"Cheow","year":"2011","journal-title":"Int J Pharm"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0355","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2011.12.045","article-title":"A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid-polymer hybrid nanoparticles","volume":"424","author":"Wang","year":"2012","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0360","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1018828425184","article-title":"Protein inhalation powders: spray drying vs spray freeze drying","volume":"16","author":"Maa","year":"1999","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0365","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jps.22299","article-title":"Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases","volume":"100","author":"Onoue","year":"2011","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.nano.2015.01.007_bb0370","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/jps.23168","article-title":"Development of budesonide nanocluster dry powder aerosols: processing","volume":"101","author":"El-Gendy","year":"2012","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0375","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11095-011-0596-1","article-title":"Condensational growth of combination drug-excipient submicrometer particles for targeted high efficiency pulmonary delivery: comparison of CFD predictions with experimental results","volume":"29","author":"Longest","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2015.01.007_bb0380","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.2147\/IJN.S34091","article-title":"New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis","volume":"7","author":"Duret","year":"2012","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0385","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/jamp.2010.0835","article-title":"Assessing the temperature of thermally generated inhalation aerosols","volume":"24","author":"Noymer","year":"2011","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0390","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11095-006-9153-8","article-title":"The effect of film thickness on thermal aerosol generation","volume":"24","author":"Myers","year":"2007","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0395","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2004.02.005","article-title":"Effect of energy on propylene glycol aerosols using the capillary aerosol generator","volume":"275","author":"Shen","year":"2004","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0400","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/jamp.2007.0672","article-title":"Anti-inflammatory effect from indomethacin nanoparticles inhaled by male mice","volume":"21","author":"Onischuk","year":"2008","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"3","key":"10.1016\/j.nano.2015.01.007_bb0405","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/jamp.2008.0721","article-title":"Analgesic effect from Ibuprofen nanoparticles inhaled by male mice","volume":"22","author":"Onischuk","year":"2009","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"16","key":"10.1016\/j.nano.2015.01.007_bb0410","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.1021\/ja8014428","article-title":"Shape-specific, monodisperse nano-molding of protein particles","volume":"130","author":"Kelly","year":"2008","journal-title":"J Am Chem Soc"},{"issue":"4","key":"10.1016\/j.nano.2015.01.007_bb0415","first-page":"A247","article-title":"Fabrication and characterization of engineered particles for respiratory drug delivery","volume":"26","author":"Fromen","year":"2013","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"941243","key":"10.1016\/j.nano.2015.01.007_bb0420","first-page":"10","article-title":"Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications","volume":"2012","author":"Garcia","year":"2012","journal-title":"J Drug Deliv"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0425","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2012.05.016","article-title":"Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles","volume":"47","author":"Yang","year":"2012","journal-title":"Eur J Pharm Sci"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0430","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijpharm.2010.03.009","article-title":"Dry powdered aerosols of diatrizoic acid nanoparticle agglomerates as a lung contrast agent","volume":"391","author":"El-Gendy","year":"2010","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.nano.2015.01.007_bb0435","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.08.010","article-title":"Enhanced dissolution of inhalable cyclosporine nano-matrix particles with mannitol as matrix former","volume":"420","author":"Yamasaki","year":"2011","journal-title":"Int J Pharm"},{"issue":"8","key":"10.1016\/j.nano.2015.01.007_bb0440","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s11095-009-9894-2","article-title":"Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery","volume":"26","author":"Sung","year":"2009","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2015.01.007_bb0445","first-page":"3489","article-title":"Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate\/nanoparticulate powders for pulmonary inhalation aerosol delivery","volume":"8","author":"Duan","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"1\u20132","key":"10.1016\/j.nano.2015.01.007_bb0450","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.03.052","article-title":"Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles","volume":"319","author":"Azarmi","year":"2006","journal-title":"Int J Pharm"},{"issue":"4","key":"10.1016\/j.nano.2015.01.007_bb0455","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ejps.2011.09.014","article-title":"Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols","volume":"44","author":"El-Gendy","year":"2011","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"10.1016\/j.nano.2015.01.007_bb0460","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2008.09.018","article-title":"Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions","volume":"71","author":"Bhavna","year":"2009","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963415000313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T12:06:51Z","timestamp":1566302811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963415000313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1549963415000313"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2015.01.007","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhalable nanoparticulate powders for respiratory delivery","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}